Jeryl L. Hilleman's most recent trade in Omada Health Inc. was a trade of 376 Common Stock done . Disclosure was reported to the exchange on July 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Omada Health Inc. | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2025 | 376 | 10,112 | - | 0 | Common Stock | |
| HilleVax Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 17,199 | 59,224 | - | 0 | Common Stock | |
| Omada Health Inc. | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 9,736 | 9,736 | - | 0 | Common Stock | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,675 | 32,815 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 16,806 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 17.26 per share. | 03 Jun 2025 | 999 | 5,591 (0%) | 0% | 17.3 | 17,247 | Ordinary Shares |
| Cutera Inc | Jeryl L. Hilleman | Director | 24 Oct 2024 | 14,673 | 40,000 | - | - | Stock Option (Right to Buy) | ||
| Cutera Inc | Jeryl L. Hilleman | Director | 12 Jul 2024 | 25,327 | 25,327 | - | - | Stock Option (Right to Buy) | ||
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,791 | 24,140 (0%) | 0% | 0 | Common Stock | |
| HilleVax Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,053 | 6,590 | - | 0 | Restricted Stock Units | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 15 Jun 2023 | 2,081 | 15,349 (0%) | 0% | 28 | 58,268 | Common Stock |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 28.74 per share. | 15 Jun 2023 | 2,081 | 17,430 (0%) | 0% | 28.7 | 59,808 | Common Stock |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 4,866 | 19,511 (0%) | 0% | 0 | Common Stock | |
| HilleVax Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,554 | 12,554 | - | - | Stock Option (Right to Buy) | |
| HilleVax Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 25,000 | 25,000 | - | - | Stock Option | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,324 | 14,645 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 13.81 per share. | 13 Jun 2022 | 1,924 | 6,321 (0%) | 0% | 13.8 | 26,562 | Common Stock |
| Minerva Neurosciences Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 2,500 | 2,500 | - | - | Stock Option (right to buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 69.61 per share. | 10 Jun 2022 | 407 | 2,537 (0%) | 0% | 69.6 | 28,331 | Ordinary Shares |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,700 | 8,700 | - | - | Options to Buy Ordinary Shares | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 33.71 per share. | 25 Jun 2021 | 4,400 | 8,245 (0%) | 0% | 33.7 | 148,324 | Common Stock |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,848 | 12,645 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,499 | 1,499 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Sale or transfer of securities back to the company at price $ 210.01 per share. | 09 Jun 2021 | 1,270 | 2,944 (0%) | 0% | 210.0 | 266,713 | Ordinary Shares |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 814 | 4,214 | - | 0 | Restricted Stock Units | |
| Talis Biomedical Corp | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 35,112 | 35,112 | - | - | Stock Option (right to buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 166.40 per share. | 18 Dec 2020 | 2,500 | 3,400 | - | 166.4 | 416,000 | Restricted Stock Units |